South Africa Central Nervous System (CNS) Therapeutic Market to 2027 - Regional Analysis and Forecasts by Disease Type (Neurovascular Diseases, Degenerative Disorders, Mental Health, Trauma, Others); Drug Type (Analgesics, Nervous System Drugs, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Geography
- THE3276282
- 76 Pages
- September 2019
- Pharmaceuticals
Rising prevalence of CNS diseases such as malnutrition, malaria, the human immunodeficiency virus & the acquired immune deficiency syndrome (HIV/AIDS), and demographic transitions are expected to surge the market growth. However, high cost of treatment is likely to have a negative impact on the growth of the market in the coming years.
According to a data of NCBI in 2014, approximately one in three South Africans will undergo a mental disorder in a lifetime, and the prevalence is higher than various low- and middle-income countries. Moreover, as per the data of South African Journal of Psychiatry, published in 2017, in a South African population-based national study, states that the prevalence of drug use was 3.7%. The highest prevalence was for cannabis, which was 3.3%, followed by sedatives or sleeping pills to be 0.8%, amphetamine-type stimulants around 0.7% and hallucinogens, to be 0.5%. Furthermore, HIV-associated dementia (HAD) is dominant in 15-30% of untreated adults with late-stage disease. The elderly patients, who previously have an increased risk of non-AIDS related dementias, are more prone to untreated HIV. Such a rising prevalence of CNS disorders is expected to create a demand for the central nervous system (CNS) therapeutic across the world.
South Africa Central Nervous System (CNS) Therapeutic market, based on Disease Type was segmented into Neurovascular Diseases, Degenerative Disorders, Mental Health, Trauma, Others). Moreover, the Degenerative Disorders segment held largest market share owing to increasing cases of diseases. . In 2016, according to World Health Organization (WHO), it was estimated that 6.1 million individuals worldwide had Parkinson's disease, and in South Africa, around three percent of the population (50 million) suffers from the disease.
South Africa central nervous system (CNS) therapeutic market, based on drug type was segmented into analgesics, nervous system drugs, anesthetics, anti-parkinson drugs, anti-epileptics, others. Moreover, analgesics segment is expected to grow at the fastest rate during the coming years because they are used to relive pain which provides relief to patients without being consciousness.
South Africa Central Nervous System (CNS) Therapeutic market, based on Distribution Channel was segmented into Hospital Pharmacies, Retail Pharmacies. In 2018, the hospitals segment held the largest share of the market, by Distribution Channel. Moreover, same segment is expected to grow at the fastest rate during the coming years because In hospitals, therapy and treatments of patients can be performed under one roof, which minimizes the need to visit pharmacies and thereby increasing the utilization of hospital settings.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
2. South Africa Central Nervous System (CNS) Therapeutic Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South Africa Central Nervous System (CNS) Therapeutic Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South Africa PEST Analysis
4.3 Expert Opinions
5. Central Nervous System (CNS) Therapeutic Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of CNS Disorders
5.2 Key Market Restraints
5.2.1 High Cost of Treatment
5.3 Key Market Opportunities
5.3.1 Increase in Geriatric Population And Associated Diseases
5.4 Future Trends
5.4.1 Increasing Wearable Devices for Central Nervous System (CNS)
5.5 Impact Analysis
6. South Africa Central Nervous System (CNS) Therapeutic Market - South Africa Market Analysis
6.1 Overview
6.2 South Africa Central Nervous System (CNS) Therapeutic Market - Revenue Forecasts and Analysis - 2018- 2027
7. South Africa Central Nervous System (CNS) Therapeutic Market Analysis- by Disease Type
7.1 Overview
7.2 South Africa Central Nervous System (CNS) Therapeutic Market, By Disease Type 2018 & 2027 (%)
7.3 Neurovascular Diseases Market
7.3.1 Overview
7.3.2 South Africa Neurovascular Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Degenerative Disorders Market
7.4.1 Overview
7.4.2 South Africa Degenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Mental Health Market
7.5.1 Overview
7.5.2 South Africa Mental Health Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Trauma Market
7.6.1 Overview
7.6.2 South Africa Trauma Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others Market
7.7.1 Overview
7.7.2 South Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. South Africa Central Nervous System (CNS) Therapeutic Market Analysis- by Drug Type
8.1 Overview
8.2 South Africa Central Nervous System (CNS) Therapeutic Market, By Drug Type 2018 & 2027 (%)
8.3 Analgesics Market
8.3.1 Overview
8.3.2 South Africa Analgesics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Anesthetics Market
8.4.1 Overview
8.4.2 South Africa Anesthetics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Anti-Parkinson Drugs Market
8.5.1 Overview
8.5.2 South Africa Anti-Parkinson Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Anti-Epileptics Drugs Market
8.6.1 Overview
8.6.2 South Africa Anti-Epileptics Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Others Drugs Market
8.7.1 Overview
8.7.2 South Africa Others Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
9. South Africa Central Nervous System (CNS) Therapeutic Market Analysis- by Distribution Channel
9.1.1 Overview
9.1.2 South Africa Central Nervous System (CNS) Therapeutic Market, By Distribution Channel 2018 & 2027 (%)
9.1.3 Hospital Pharmacies Market
9.1.4 Overview
9.1.5 South Africa Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6 Retail Pharmacies Market
9.1.6.1 Overview
9.1.6.2 South Africa Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. Central Nervous System (CNS) Therapeutic Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies done by the companies in the Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic developments
10.4.1 Overview
11. Central Nervous System (CNS) Therapeutic Market-Key Company Profiles
11.1 Eli Lilly and company
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Pfizer Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Merck & Co., Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 AstraZeneca
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Information
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Takeda Pharmaceutical Company Limited
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Information
11.6.4 Product Pipeline
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Lundbeck
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Adcock Ingram
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Lupin Limited
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Information
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
Table 1. Organic Developments Done By Companies
Table 2. Inorganic developments done by Companies
Table 3. Glossary of Terms, Central Nervous System (CNS) Therapeutic Market
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
